Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04286009 · ClinicalTrials.gov registry record
Pathogenesis and Mechanisms of Mitral Annular Calcification
A clinical trial of Mitral Annulus Calcification, sponsored by Mayo Clinic.
- Completed
- Registry status
- 45
- Enrollment target
- 1
- Study location
NCT04286009 is a study of Mitral Annulus Calcification that has completed, run by Mayo Clinic. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04286009, a study of Mitral Annulus Calcification, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are testing blood or mitral valve tissue to better understand the reasons why Mitral Annular Calcification (MAC) develops in patients with heart disease.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2020-07-28 |
| Est. Completion | 2024-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04286009
The ClinicalTrials.gov registry entry for NCT04286009 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mitral Annulus Calcification appearing as the primary indexed condition, and to 0 interventions.
NCT04286009 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04286009 about?
NCT04286009 is a clinical study titled "Pathogenesis and Mechanisms of Mitral Annular Calcification". Researchers are testing blood or mitral valve tissue to better understand the reasons why Mitral Annular Calcification (MAC) develops in patients with heart disease.
What is the current status of trial NCT04286009?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2020-07-28. Estimated completion is 2024-04-01.
What conditions does trial NCT04286009 study?
This clinical trial studies the following conditions: Mitral Annulus Calcification.
Who is sponsoring clinical trial NCT04286009?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04286009 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mitral Annulus Calcification
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.